Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

PD-1 (human), (recombinant)

ENZ-PRT190-0050 50 µg 395.00 USD
Do you need bulk/larger quantities?

Product Details

Alternative Name:Programmed cell death-1, CD279, Programmed death receptor 1
MW:~20.5kDa (actual is a doublet at 40kDa and 50kDa that is immunoactive with PD-1)
Source:Produced in HEK cells. Extracellular domain of PD-1 (aa 25-167) containing a 5’-His-tag, V5 epitope tag spacer, and a FLAG-tag.
UniProt ID:Q15116
Formulation:Lyophilized. Contains PBS.
Purity:≥90% (SDS-PAGE)
Endotoxin Content:<100 EU/mg 
Biological Activity:Binds to PD-L1.
Shipping:Blue Ice Not Frozen
Long Term Storage:-20°C
Handling:Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C.
Scientific Background:PD-1 (programmed cell death-1) is a transmembrane protein important for regulating immune responses. It is a member of the CD28/CTLA-4 family of immunoreceptors and is expressed on T cells and pro-B cells suggesting it has a broad spectrum of immune regulation. PD-1 along with its two ligands, PD-L1 and PD-L2, prevent the activation of T cells and protect tissues from autoimmune attack. PD-1 and its ligands are also involved in reduction of infectious immunity, as well as tumor immunity. PD-1 has been shown to facilitate chronic infection and tumor progression. Drugs targeting PD-1 have shown promise in treating cancer and HIV and may be important in a variety of immune related disorders.
Technical Info/Product Notes:FLAG is a registered trademark of Sigma-Aldrich Co.
Regulatory Status:RUO - Research Use Only
PD-1 (human), (recombinant) Flow Cytometry
PD-1 Activity. PD-1 activity is in the range of 100 – 25,000 ng/ml. This was done by measuring PD-1’s ability to bind to human PD-L1 (B7-H1) that was immobilized onto magnetic beads. Briefly, PD-1 was titered into the assay, which contained PD-L1 coated magnetic beads and goat anti – human PD-1 conjugated to phycoerythrin (PE). The reactions were incubated for 1 hour at room temperature, washed 3X with PBS, and resuspended in PBS. Each reaction was analyzed by measuring median PE intensity on a BD FacsCalibur cytometer.
PD-1 (human), (recombinant) Western blot
Western Blot Analysis. Lane 1, Molecular weight marker. Lane 2, 100ng PD-1. Probed with mouse anti-PD-1 monoclonal antibody.
PD-1 (human), (recombinant) SDS-PAGE
Coomassie stained SDS-PAGE. Lane 1, Molecular weight marker. Lane 2, 1.0 µg PD-1.
PD-1 (human), (recombinant) Western blot
Western Blot Analysis. Lane 1, Molecular weight marker. Lane 2, 100ng PD-1. Probed with rabbit anti-FLAG polyclonal antibody.
Please mouse over
PD-1 (human), (recombinant) Flow Cytometry PD-1 (human), (recombinant) Western blot PD-1 (human), (recombinant) SDS-PAGE PD-1 (human), (recombinant) Western blot

Product Literature References

A new catalytic site functioning in antigen cleavage by H34 catalytic antibody light chain: E. Hifumi, et al.; Sci. Rep. 12, 19185 (2022), Abstract;

General Literature References

PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy: D.E. Dolan, et al.; Cancer Control 21, 231 (2014), Abstract; Full Text
Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection: E.A. Said, et al.; Nat. Med. 16, 452 (2010), Abstract; Full Text
The PD-1 pathway in tolerance and autoimmunity: L.M. Francisco, et al.; Immunol. Rev. 236, 219 (2010), Abstract; Full Text
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms: R.V. Parry, et al.; Mol. Cell. Biol. 25, 9543 (2005), Abstract; Full Text
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade: Y. Iwai, et al. ; PNAS 99, 12293 (2002), Abstract; Full Text
Engagement of the Pd-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation: J.F. Gordon, et al.; J. Exp. Med. 192, 1027 (2000), Abstract; Full Text

Related Products

PD-L1 (human), (recombinant) 

Produced in HEK cells. Human PD-L1 (aa 19-239) is fused at the N-terminus to a His-tag and FLAG®-tag., ≥90% (SDS-PAGE) | Print as PDF
ENZ-PRT223-0100 100 µg 619.00 USD
Do you need bulk/larger quantities?

Product Toolbox


Certificate of Analysis


By target:
Programmed cell death
By biological activity:
Programmed cell death Recombinant protein
By catalog section:


Technical Service
Customer Service